focus -WSS

focus

author：entertainment 2025-09-28 19:19:02 - browse：43

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

hotspot

Wikipedia

WSS

Opioid cravings were reduced by anti

An interview with Robert F. Kennedy Jr. on vaccines

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Reporting on presidential health from Reagan to Trump and Biden

As AI regulations shape up, health tech startups beg for clarity

Reporting on presidential health from Reagan to Trump and Biden

leisure time

focus

leisure time

Jerome Adams on the need for new antivirals for Covid

Medicare Advantage enrollment hits roughly 33.4 million

Continuity nursing helped my family in our darkest PICU moments

MD Anderson's Padmanee Sharma responds to research credit suit

Walensky prepares to leave CDC — and Congress — behind

In 'major milestone,' FDA approves first cell therapy for solid tumors

In age of alternative facts, a scholarly course on calling out crap

Flagship Pioneering startup Sonata Therapeutics lays off 21

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Wikipedia

Measles policy set amid Florida outbreak alarms vaccine proponents

Majority of Americans think Trump's Ga. election interference case is serious: POLL

FDA warns medical device makers about rise in fabricated data

An interview with Robert F. Kennedy Jr. on vaccines

Listen: Racing for gene therapy & a pioneering approval

The boys, now 6, who are gene therapy’s ‘edge case’ problem

knowledge

hotspot

Wikipedia

Wikipedia